Table 1.
Pre-transplant Characteristics of Cases and Controls.
| Characteristics | Cases (n = 13, 14 OLTs) | Controls (n = 28) | P-value |
|---|---|---|---|
| Demographics | |||
| Age at LT (yrs) ± SD (range) | 45.5 ± 8.7 (30–61) | 46.32 ± 9.32 (25–64) | 0.8 |
| Male/female | 5/8 (females 62%) | 16/12 (females 43%) | 0.5 |
| Race (Caucasian/African-American/Other) | 2/11 (African-American 85%) | 22/5/1 (African-American 18%) | <.0001 |
| Laboratory data | |||
| Serum total bilirubin (mg/dL) | 8.9 (0.6–18) | 5 (1–33) | .102 |
| Serum alkaline phosphatase (IU/L) | 353 (85–1100) | 297 (77–1100) | .91 |
| AST (IU/L) | 88 (39–209) | 154 (33–1600) | .30 |
| ALT (IU/L) | 71 (15–172) | 96 (13–1200) | .72 |
| Serum albumin (g/dL) | 2.6 (1.7–4.2) | 3.0 (1.4–4.1) | .44 |
| MELD | 19 (9–29) | 19 (7–37) | .94 |
| Serum creatinine (mg/dL) | 1.1 (0.6–2.6) | 1.0 (.6–4.5) | .74 |
| INR | 1.4 (1.0–2.4) | 1.3 (0.9–2.0) | .83 |
Data are reported as median (range) except gender and race that are expressed as numbers.